BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2444612)

  • 1. Rapid gas chromatographic determination of phytanic acid from serum of a patient suffering from Refsum's disease.
    Cingolani L
    J Chromatogr; 1987 Aug; 419():475-8. PubMed ID: 2444612
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of phytanic acid (3,7,11,15-tetramethylhexadecanoic acid) in serum using the gas chromatograph GCHF 18.3].
    Pilz D; Kühn HJ
    Psychiatr Neurol Med Psychol (Leipz); 1984 Sep; 36(9):556-8. PubMed ID: 6083570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Di-, mono- and nonphytanyl triglycerides in the serum: a sensitive parameter of the phytanic acid accumulation in Refsum's disease.
    Molzer B; Bernheimer H; Barolin GS; Höfinger E; Lenz H
    Clin Chim Acta; 1979 Jan; 91(2):133-40. PubMed ID: 83207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple capillary gas chromatographic method for the quantitation of phytanic acid in serum.
    Jacob K; Mehlin S; Knedel M; Vogt W
    J Chromatogr; 1986 Jan; 374(2):354-7. PubMed ID: 2420814
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of formic acid in carrier gas. Rapid method for identification and determination of phytanic acid by gas chromatography-mass spectrometry-chemical ionization.
    Pileire B; Beaune P; Laudat MH; Cartier P
    J Chromatogr; 1980 Jun; 182(3-4):269-76. PubMed ID: 6156182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
    Skjeldal OH; Stokke O; Refsum S; Norseth J; Petit H
    J Neurol Sci; 1987 Jan; 77(1):87-96. PubMed ID: 2433405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dietary treatment of a patient with Refsum's syndrome (clinical and chemical course observation during a phytol and phytanic acid-poor diet)].
    Thümler R; Atzpodien W; Kremer GJ
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1084-6. PubMed ID: 77097
    [No Abstract]   [Full Text] [Related]  

  • 8. The significance of plasma phytanic acid levels in adults.
    Britton TC; Gibberd FB; Clemens ME; Billimoria JD; Sidey MC
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):891-4. PubMed ID: 2475586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange.
    Gibberd FB; Billimoria JD; Page NG; Retsas S
    Lancet; 1979 Mar; 1(8116):575-8. PubMed ID: 85164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refsum's disease: management by diet and plasmapheresis.
    Hungerbühler JP; Meier C; Rousselle L; Quadri P; Bogousslavsky J
    Eur Neurol; 1985; 24(3):153-9. PubMed ID: 2581787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is phytanate accumulation pathognomonic for heredopathia atactica polyneuritiformis?
    Aldenhövel HB
    Arch Neurol; 1990 Sep; 47(9):952. PubMed ID: 1697747
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase.
    Poulos A; Sharp P; Fellenberg AJ; Danks DM
    Hum Genet; 1985; 70(2):172-7. PubMed ID: 2408988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infantile phytanic acid storage disease, a possible variant of Refsum's disease: three cases, including ultrastructural studies of the liver.
    Scotto JM; Hadchouel M; Odievre M; Laudat MH; Saudubray JM; Dulac O; Beucler I; Beaune P
    J Inherit Metab Dis; 1982; 5(2):83-90. PubMed ID: 6188882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heredopathia atactica polyneuritiformis (Refsum's disease): 2. Estimation of phytanic acid in foods.
    Masters-Thomas A; Bailes J; Billimoria JD; Clemens ME; Gibberd FB; Page NG
    J Hum Nutr; 1980 Aug; 34(4):251-4. PubMed ID: 6157717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Refsum disease with atypical clinical picture in family members.
    Marano R; Soliveri P; Garavaglia B; Antonelli A; Girotti F
    Ital J Neurol Sci; 1989 Aug; 10(4):451-4. PubMed ID: 2477346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease.
    Greter J; Lindstedt S; Steen G
    Clin Chem; 1983 Mar; 29(3):434-7. PubMed ID: 6186413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refsum's disease and metabolism of phytanic acid.
    Stokke O; Refsum S
    Lancet; 1982 Apr; 1(8277):906-7. PubMed ID: 6175864
    [No Abstract]   [Full Text] [Related]  

  • 18. Age-related accumulation of phytanic acid in plasma from patients with the cerebro-hepato-renal (Zellweger) syndrome.
    Wanders RJ; Smit W; Heymans HS; Schutgens RB; Barth PG; Schierbeek H; Smit GP; Berger R; Przyrembel H; Eggelte TA
    Clin Chim Acta; 1987 Jun; 166(1):45-56. PubMed ID: 2440622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple and rapid method for the quantitation of plasma phytanic acid by gas chromatography.
    Cingolani L; Croci D
    J Chromatogr; 1985 May; 339(2):375-9. PubMed ID: 4008577
    [No Abstract]   [Full Text] [Related]  

  • 20. 3-Methyladipate excretion in Refsum's disease.
    Brenton DP; Krywawych S
    Lancet; 1982 Mar; 1(8272):624. PubMed ID: 6174838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.